Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Pawel Petryszyn"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Background: Current management of ulcerative colitis (UC) is aimed to treat active disease and to maintain remission. For patients in whom conventional treatment is no longer effective, biological or small molecule therapy may be an option. The aim w
Externí odkaz:
https://doaj.org/article/daf5907b60e64d0cbf709ccf548bcea5
Autor:
Pawel Petryszyn, Piotr Niewinski, Aleksandra Staniak, Patryk Piotrowski, Anna Well, Michal Well, Izabela Jeskowiak, Gregory Lip, Piotr Ponikowski
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213198 (2019)
BackgroundMany atrial fibrillation patients eligible for oral anticoagulants are unaware of the presence of AF, and improved detection is necessary to facilitate thromboprophylaxis against stroke.ObjectiveTo assess the effectiveness of screening for
Externí odkaz:
https://doaj.org/article/a00dddf6b9cb4856a8bc3bc5a97aa919
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:1306-1312
Colonoscopy is the standard medical procedure to identify inflammatory bowel disease (IBD) in patients with gastrointestinal symptoms. Noninvasive measurement of faecal calprotectin concentration may replace colonoscopy in this indication. The study
Autor:
Agnieszka Gruca, Ewa Jaźwińska-Tarnawska, Elżbieta Poniewierka, Anna Wiela-Hojeńska, Krystyna Głowacka, Pawel Petryszyn, Robert Dudkowiak, Paweł Ekk-Cierniakowski
Publikováno v:
Genes
Volume 12
Issue 9
Genes, Vol 12, Iss 1419, p 1419 (2021)
Volume 12
Issue 9
Genes, Vol 12, Iss 1419, p 1419 (2021)
P-glycoprotein encoded by the ABCB1 gene constitutes a molecular barrier in the small and large bowel epithelium, and its different expression may influence susceptibility to inflammatory bowel disease (IBD). We aimed to assess the contribution of th
Autor:
Catherine Le Berre-Scoul, Driffa Moussata, Iva Jirka, Raphael Olivier, Maxime Leroy, Jean-François Mosnier, Tamara Matysiak-Budnik, Pawel Petryszyn, Michel Neunlist, Nicolas Chapelle, Dominique Lamarque, David Tougeron, Justine Blin
Publikováno v:
Helicobacter
Helicobacter, Wiley, 2020, 25 (5), ⟨10.1111/hel.12727⟩
Helicobacter, Wiley, 2020, 25 (5), ⟨10.1111/hel.12727⟩
International audience; Background: Analysis of serum biomarkers for the assessment of atrophic gastritis (AG), considered as gastric precancerous lesion, is of growing interest and recommended by current guidelines. Our aim was to evaluate the diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec842c5958541f3ec2b42c2e99bcf656
https://hal.archives-ouvertes.fr/hal-02984271
https://hal.archives-ouvertes.fr/hal-02984271
Publikováno v:
Digestive diseases (Basel, Switzerland). 38(4)
Background: Despite its decreasing incidence, gastric cancer (GC) remains one of the leading cancers in the world and an important global healthcare problem due to its overall high prevalence and high mortality rate. Summary: GC is a consequence of H
Autor:
Anna Wiela-Hojeńska, Pawel Petryszyn
Publikováno v:
Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 27(10)
Crohn's disease (CD) and ulcerative colitis (UD) are the 2 common clinical subtypes of idiopathic inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract. The multifactorial etiology and pathogenesis of IB
Publikováno v:
Journal of Comparative Effectiveness Research. 5:169-178
Objectives: To compare the cost-effectiveness of therapy of gastroesophageal reflux disease with esomeprazole and other proton pump inhibitors (PPIs) in Poland. Materials & methods: Studies comparing esomeprazole with other PPIs in the treatment of e
Autor:
Leszek Paradowski, Pawel Petryszyn
Publikováno v:
Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 27(6)
BACKGROUND Crohn's disease (CD) and ulcerative colitis (UC) typically clinically manifest with symptoms like chronic diarrhea, cramps, abdominal pain, and rectal bleeding. However, symptoms of abnormal anorectal function seem to be of equal importanc
Autor:
Pawel Petryszyn, Leszek Paradowski
Publikováno v:
Przegla̜d Gastroenterologiczny
In the early 90s American authors estimated that if a theoretical new drug was introduced that was capable of changing the natural course of the disease and reducing direct non-drug medical costs (including hospitalisation and surgery) by 20%, despit